Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab: A stepwise, safety and patient-orientated process towards sustainability

BACKGROUND: Infliximab and other intravenous biologic infusions are increasingly used for chronic disorders like inflammatory bowel disease (IBD). Rapid infliximab and home-based infusions are attractive solutions to address resource and capacity issues for infusion centres, yet infliximab infusion...

Descripción completa

Detalles Bibliográficos
Autores principales: Bohra, Anuj, Rizvi, Qurat-Al-Ain, Keung, Charlotte Yuen Yu, Vasudevan, Abhinav, van Langenberg, Daniel R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520608/
https://www.ncbi.nlm.nih.gov/pubmed/33024395
http://dx.doi.org/10.3748/wjg.v26.i36.5437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520608/
https://www.ncbi.nlm.nih.gov/pubmed/33024395
http://dx.doi.org/10.3748/wjg.v26.i36.5437

Ejemplares similares